Singapore · Delayed Price · Currency is SGD Nations Trust Bank Statistics
Total Valuation
iX Biopharma has a market cap or net worth of SGD 348.78 million. The enterprise value is 338.19 million.
| Market Cap | 348.78M |
| Enterprise Value | 338.19M |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +7.68% |
| Shares Change (QoQ) | +3.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 631.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 49.82 |
| PB Ratio | 20.52 |
| P/TBV Ratio | 20.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 48.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.35.
| Current Ratio | 2.31 |
| Quick Ratio | 2.14 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.02 |
| Interest Coverage | -8.76 |
Financial Efficiency
Return on equity (ROE) is -53.78% and return on invested capital (ROIC) is -32.09%.
| Return on Equity (ROE) | -53.78% |
| Return on Assets (ROA) | -19.32% |
| Return on Invested Capital (ROIC) | -32.09% |
| Return on Capital Employed (ROCE) | -31.85% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 200,029 |
| Profits Per Employee | -133,429 |
| Employee Count | 35 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 5.13 |
Taxes
In the past 12 months, iX Biopharma has paid 2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,733.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +1,733.33% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.18 |
| Relative Strength Index (RSI) | 42.42 |
| Average Volume (20 Days) | 8,596,115 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, iX Biopharma had revenue of SGD 7.00 million and -4.67 million in losses. Loss per share was -0.01.
| Revenue | 7.00M |
| Gross Profit | 2.14M |
| Operating Income | -5.97M |
| Pretax Income | -4.67M |
| Net Income | -4.67M |
| EBITDA | -5.68M |
| EBIT | -5.97M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 16.49 million in cash and 5.90 million in debt, with a net cash position of 10.59 million.
| Cash & Cash Equivalents | 16.49M |
| Total Debt | 5.90M |
| Net Cash | 10.59M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 17.00M |
| Book Value Per Share | 0.02 |
| Working Capital | 11.26M |
Cash Flow
In the last 12 months, operating cash flow was -5.72 million and capital expenditures -73,000, giving a free cash flow of -5.80 million.
| Operating Cash Flow | -5.72M |
| Capital Expenditures | -73,000 |
| Depreciation & Amortization | 296,000 |
| Net Borrowing | 195,000 |
| Free Cash Flow | -5.80M |
| FCF Per Share | n/a |
Margins
Gross margin is 30.51%, with operating and profit margins of -85.30% and -66.70%.
| Gross Margin | 30.51% |
| Operating Margin | -85.30% |
| Pretax Margin | -66.68% |
| Profit Margin | -66.70% |
| EBITDA Margin | -81.07% |
| EBIT Margin | -85.30% |
| FCF Margin | n/a |
Dividends & Yields
iX Biopharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.68% |
| Shareholder Yield | -7.68% |
| Earnings Yield | -1.34% |
| FCF Yield | -1.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |